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Abstract
Background: The usefulness of available vaccine and serological tests for leptospirosis is limited
by the low cross-reactivity of antigens from numerous serovars of pathogenic Leptospira spp.
Identification of genus-specific protein antigens (GP-Ag) of Leptospira would be important for
development of universal vaccines and serodiagnostic methods. OmpL1, a transmembrane porin of
pathogenic leptospires, was identified as a possible GP-Ag, but its sequence diversity and immune
cross-reactivity among different serovars of pathogenic leptospires remains largely unknown.
Results: PCR analysis demonstrated that the ompL1 gene existed in all 15 official Chinese standard
strains as well as 163 clinical strains of pathogenic leptospires isolated in China. In the standard
strains, the ompL1 gene could be divided into three groups (ompL1/1, ompL1/2 and ompL1/3)
according to their sequence identities. Immune electron microscopy demonstrated that all
products of the different gene types of ompL1 are located on the surface of leptospires. The
microscopic agglutination test revealed extensive yet distinct cross-immunoagglutination among
the antisera against recombinant OmpL1 (rOmpL1) and leptospiral strains belonging to different
ompL1 gene types. These cross-immunoreactions were further verified by ELISAs using the OmpL1
proteins as the coated antigens in serum samples from 385 leptospirosis patients. All the antisera
against rOmpL1 proteins could inhibit L. interrogans strain Lai from adhering to J774A.1 cells.
Furthermore, immunization of guinea pigs with each of the rOmpL1 proteins could cause cross-
immunoprotection against lethal challenge with leptospires from different ompL1 gene types.
Conclusion: Three types of the ompL1 gene are present in pathogenic leptospires in China.
OmpL1 is an immunoprotective GP-Ag which should be considered in the design of new universal
vaccines and serodiagnostic methods against leptospirosis.
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Background
Leptospirosis, caused by infection with pathogenic Lept-
ospira species belonging to different serogroups and sero-
vars, is one of the most prevalent zoonotic diseases in the
world [1-3]. A wide variety of serogroups and serovars
have been identified along with endemicity which varies
from region to region [4-6]. The leptospiral vaccines used
currently are mainly multivalent dead whole-cell mixtures
made of several local dominant serovars in different coun-
tries and regions. These vaccines, however, do not confer
cross-protective immunity to the serogroups that are not
represented in the vaccine [7,8], allowing the unrepre-
sented serovars to continue causing outbreaks of lept-
ospirosis. For instance, in a central province, Anhui, and
an eastern province, Zhejiang, of China, L. interrogans
serogroup Sejroe serovar Medanensis caused local out-
breaks of leptospirosis [9-12]. In addition, vaccination
with the whole-cell vaccines may lead to incomplete,
short-term immunity as well as serious side effects [13-
15]. A universal vaccine against leptospirosis is not avail-
able yet, making the identification of genus-specific pro-
tein antigens (GP-Ag) that display extensive cross-
immunity very valuable for developing new vaccines and
serodiagnostic methods.
Outer membrane proteins (Omps) are important patho-
genic components and highly conserved in different sero-
groups and serovars of pathogenic leptospires. OmpL1, a
transmembrane Omp with 320 amino acid residues, first
reported by Haake and his colleagues in 1993, is a porin
expressed by all the tested pathogenic Leptospira species
[16-19]. However, the diversity of ompL1 gene sequences
from different pathogenic Leptospira spp. and the distribu-
tion of the ompL1 gene in clinical isolates had not been
characterized until now. Moreover, the cross-immuno-
genicity and immunoprotective effects of OmpL1 were
mostly unknown.
In this study, we sequenced and analyzed ompL1 genes
cloned from standard pathogenic strains of leptospires
prevalent in China. Several prokaryotic recombinant
products of the gene (rOmpL1) were expressed and their
rabbit antisera were prepared. rOmpL1-based ELISAs were
established to examine specific antibodies in sera from
leptospirosis patients. In parallel, the microscopic aggluti-
nation test (MAT) was performed to detect the cross-
immunoagglutination of different antisera against
rOmpL1 proteins, and immunoelectron microscopy
(IEM) was employed to localize OmpL1 on the lepto-
spires. Finally, immunoprotection of rOmpL1 was tested
in guinea pigs. Taken together, our results suggest that
OmpL1 could be used as a major component of a univer-
sal and efficient immunogen for vaccination and also for
diagnosis of leptospirosis.
Results
Amplification of ompL1 genes in the standard and clinical 
strains
All the 15 standard strains and 163 isolates of pathogenic
Leptospira species (Table 1) carried the ompL1 gene, since
amplicons with the expected size were produced by PCR
from all the strains and isolates (data no shown).
Molecular phylogeny and gene-typing of ompL1 gene
Based on the molecular phylogenetic relationship of their
nucleotide sequences (GenBank Accession No.:
AY622658–AY622672) and putative amino acid
sequences (Figure 1, see Additional file 1 for details),
ompL1 genes from the pathogenic leptospires could be
classified into three groups: ompL1/1, ompL1/2 and ompL1/
3 (Table 2). Sequence identity of the putative amino acid
sequences between ompL1/1 and ompL1/2, ompL1/1 and
ompL1/3, and ompL1/2  and  ompL1/3  gene types was
92.50%–93.44%, 85.31%–86.88%, and 85.31%–
86.25%, respectively. In addition, the ompL1  gene
sequencing data of 39 clinical strains also supported the
classification into three groups (Table 2). Both the nucle-
otide and putative amino acid sequence identities among
the clinical strains with the same ompL1 gene type were
above 98% (data not shown).
Data of secondary structure analysis of OmpL1 proteins
All the three gene types of OmpL1 proteins had very sim-
ilar predicted secondary structures and antigenic indexes
(Figure 2, see Additional file 2 for details). The OmpL1
proteins had five main putative surface-membrane
regions (70–80, 115–120, 145–150, 235–245, 305–310
amino acid residuals) and seven transmembrane regions
(10–40, 120–130, 160–190, 215–225, 240–250, 270–
280, and 295–305 amino acid residues). The only salient
different was the presence of less alpha-helix in the N-ter-
minal and beta-sheet in the C-terminal region of the
OmpL1/3 sequence, compared to the sequences of
OmpL1/1 and OmpL1/2.
Identification of expressed rOmpL1 proteins and titers of 
rabbit antisera
rOmpL1/1, rOmpL1/2 and rOmpL1/3 were well
expressed after induction with IPTG and showed single
bands in gel after purification by Ni-NTA-chromatogra-
phy (Figure 3). Western blot analysis also indicated that
serum samples from leptospirosis patients could recog-
nize rOmpL1 proteins (Figure 4), implying that the pro-
teins are immunogenic during natural infection.
Immunodiffusion titers of all the rabbit antisera against
rOmpL1 proteins were at least 1:4.
Localization of OmpL1 proteins on leptospires
Using anti-rOmpL1/1, anti-rOmpL1/2 and anti-rOmpL1/
3 sera as the primary antibodies, all the colloidal gold par-BMC Microbiology 2008, 8:223 http://www.biomedcentral.com/1471-2180/8/223
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ticles conjugated to secondary antibodies were bound on
the surface of L. interrogans serovar Autumnalis strain Lin
4 (ompL1/1 gene type), serovar Lai strain Lai (ompL1/2
gene type), and L. borgpetersenii serovar Ballum strain
Pishu (ompL1/3 gene type) (Figure 5).
Titers of MAT
The antisera against rOmpL1/1, rOmpL1/2 and rOmpL1/
3 were able to cross-agglutinate with MAT titers of 1:100
to 1:800 for all the 15 standard strains and 163 clinical
strains of pathogenic leptospires (Table 3).
Detection of antibodies against rOmpL1 proteins in 
leptospirosis patients
In ELISA assays using rOmpL1/1, rOmpL1/2 and
rOmpL1/3, the positive rates for IgG in specimens from
385 leptospirosis patients using 1:100 and 1:200 serum
dilutions were 87.8% (338/385) and 78.2% (301/385),
95.1% (366/385) and 82.1% (316/385), and 77.7%
(299/385) and 65.5% (252/385), respectively (Table 4).
When using 1:50 and 1:100 serum dilutions from the
same specimens, the positive rates for IgM were 83.4%
(321/385) and 72.7% (280/385), 87.0% (335/385) and
77.4% (298/385), and 74.3% (286/385) and 63.1%
(243/385), respectively (Table 4).
Inhibition of adherence by antisera against rOmpL1 
proteins
Anti-rOmpL1/1 (1:200 dilution), anti-rOmpL1/2 (1:300
dilution) or anti-rOmpL1/3 (1:50 dilution) sera could
completely inhibit the adherence of L. interrogans serovar
Lai strain Lai to macrophages (Figure 6), demonstrating
cross-inhibition effects among the different anti-sera.
Immunoprotection due to immunization with rOmpL1 
proteins
Immunization of guinea pigs with rOmpL1/1, rOmpL1/2
and rOmpL1/3 conferred a significant level of resistance
Table 1: Background information on the leptospiral strains and serum specimens
Strain/Sera Serovar Serogroup Genospecies
Standard strains (n = 15)
Lai Lai Icterohaemorrhagiae L. interrogans
Lin Canicola Canicola L. interrogans
Tian Pyrogenes Pyrogenes L. interrogans
Lin 4 Autumnalis Autumnalis L. interrogans
65-9 Australis Australis L. interrogans
Luo Pomona Pomona L. interrogans
Lin 6 Grippotyphosa Grippotyphosa L. interrogans
P 7 Hebdomadis Hebdomadis L. interrogans
L 37 Paidjan Bataviae L. interrogans
L 183 Wolffi Sejroe L. interrogans
M 10 Javanica Javanica L. borgpetersenii
Pishu Ballum Ballum L. borgpetersenii
55-52 Tarassovi Tarassovi L. borgpetersenii
Nan 10 Mini Mini L. borgpetersenii
L 105 Manhao 2 Manhao L. weilii
Isolates (n = 163)
85 Lai Icterohaemorrhagiae L. interrogans
5 Canicola Canicola L. interrogans
4 Autumnalis Autumnalis L. interrogans
18 Pomona Pomona L. interrogans
11 Grippotyphosa Grippotyphosa L. interrogans
15 Hebdomadis Hebdomadis L. interrogans
20 Medanesis Sejroe L. interrogans
5 Australis Australis L. interrogans
Patient sera (n = 385)
191 Lai Icterohaemorrhagia L. interrogans
11 Canicola Canicola L. interrogans
13 Autumnalis Autumnalis L. interrogans
37 Pomona Pomona L. noguchii
31 Grippotyphosa Grippotyphosa L. interrogans
44 Hebdomadis Hebdomadis L. interrogans
45 Medanesis Sejroe L. interrogans
13 Australis Australis L. interrogans
Normal sera (n = 36) / / /BMC Microbiology 2008, 8:223 http://www.biomedcentral.com/1471-2180/8/223
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against lethal challenge with pathogenic leptospires from
the three different ompL1 groups (Table 5). However, the
immunoprotective rates against the same ompL1 gene type
leptospiral infection as the immunizing recombinant pro-
tein (62.5%–87.5%) were higher than when strains and
proteins from different ompL1  gene types were used
(25.0%–62.5%).
Discussion
Outer membrane proteins exposed on the surface of lept-
ospires are known to react with the host cell and environ-
ment. Interestingly, lipopolysaccharide fractions confer
protective immunity against challenge with homologous
but not heterogonous leptospires, whereas protein extract
induced significant protection against both types of chal-
lenge [20]. Thus far, a number of outer membrane pro-
teins of leptospires, such as OmpL1, LipL32, LipL36,
LipL41, LigA and LigB, have been cloned and character-
ized, and some of them have been shown to stimulate
specific immunity in animal models [21-24]. Among all
the leptospiral Omps, OmpL1 is a unique transmembrane
protein that was confirmed to function as a porin, contrib-
ute to the survival of leptospires, and display synergetic
immunoprotection with LipL41 [16-18]. However, major
questions such as the distribution of ompL1 gene types in
leptospiral strains, the exact localization of OmpL1, and
cross-immunogenicity and immunoprotective effects of
OmpL1 proteins remain unaddressed.
This study reveals that the ompL1 gene is present in the
genomes of all the pathogenic leptospires tested. Accord-
ing to our alignment and phylogenetic analysis from the
15 standard strains of pathogenic Leptospira spp., three
groups of ompL1  (ompL1/1,  ompL1/2 and ompl/3) exist.
However, the predicted secondary structure of the OmpL1
proteins revealed that there is little difference among the
three groups. Thus, the differences in nucleotide
sequences in the ompL1  gene types may not affect the
immunogenicity and OmpL1 proteins, identifying
OmpL1 as a genus-specific protein antigen.
Surface exposure is a key characteristic for an effective
antigen. Although OmpL1 may be an outer membrane
protein according to previous reports, the precise localiza-
tion of OmpL1 still remained unclear. Leptospires possess
both inner and outer membranes, but only the proteins
expressed in the outer membrane are capable of interact-
ing with the host immune system. To begin to characterize
the localization, we used the prokaryotic recombinant
expression technique to obtain a large amount of homo-
geneous OmpL1 proteins for preparation of immunore-
sponsive antisera from rabbits. Visualization by immuno-
electron microscopy using anti-OmpL1 anti-sera con-
firmed that OmpL1 is located at the surface of the outer
membrane of leptospires. MAT is a standard method for
serodiagnosis of leptospirosis and serological classifica-
tion of leptospires, for which live leptospiral cells are typ-
Table 2: ompL1 gene types of standard strains and isolates of Leptospires
Species Serogroup Serovar Strain (n) ompL1 gene type
123
L. interrogans Icterohaemorrhagiae Lai Lai √
Wild (5) √
L. interrogans Canicola Canicola Lin √
Wild (5) √
L. interrogans Australis Australis 65-9 √
Wild (5) √
L. interrogans Pomona Pomona Luo √
Wild (5) √
L. interrogans Hebdomadis Hebdomadis P 7 √
Wild (5) √
L. interrogans Autumnalis Autumnalis Lin 4 √
Wild (4) √
L. interrogans Grippotyphosa Grippotyphosa Lin 6 √
Wild (5) √
L. interrogans Sejroe Wolffi L 183 √
Medanesis Wild (5) √
L. interrogans Bataviae Paidjan L 37 √
L. interrogans Pyrogenes Pyrogenes Tian √
L. borgpetersenii Javanica Javanica M 10 √
L. borgpetersenii Ballum Ballum Pishu √
L. borgpetersenii Tarassovi Tarassovi 55-52 √
L. borgpetersenii Mini Mini Nan 10 √
L. weilii Manhao Manhao II L 105 √BMC Microbiology 2008, 8:223 http://www.biomedcentral.com/1471-2180/8/223
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ically used [23]. In this study, we used MAT to examine
cross-immunoagglutination among the antisera from
rOmpL1 proteins and a large number of strains belonging
to different pathogenic leptospiral serogroups/serovars.
The results indicated that there is extensive cross-immu-
noagglutination between the different ompL1 gene types
of pathogenic leptospiral strains and the OmpL1 antisera,
and not surprisingly, the highest agglutination was
observed between antisera from the same ompL1  gene
types as the leptospiral strains. Furthermore, ELISA results
revealed that OmpL1s-specific antibodies are produced in
all the sera from leptospirosis patients, and the trends in
cross-immunoreactivities in the different ELISA tests are
also similar to those of MAT.
At least 75 serovars of pathogenic leptospires belonging to
18 serogroups have been found to date in China, but only
a few of them frequently cause leptospirosis. According to
the annual reports on leptospirosis from Chinese CDCs,
L. interrogans serogroup Icterohaemorrhagiae serovar Lai
is the most dominant pathogenic leptospires, responsible
for approximately 75% of the morbidity in the country.
The other pathogenic leptospires causing leptospirosis are
the Grippotyphosa, Autumnalis, Australis, Pomona and
Hebdomadis serovars [3,11,25]. Our study showed that
all the 163 clinical strains of different pathogenic Lept-
ospiral serogroup/serovars belong to either the ompL1/1
or ompL1/2 group (data not shown). Thus, we conclude
that leptospires from the ompL1/1 and ompL1/2 groups are
the most prevalent strains in China.
In this study, immunization with either rOmpL1/1,
rOmpL1/2 or rOmpL1/3 proteins could enhance signifi-
cantly survival of guinea pigs lethally challenged with
pathogenic Leptospira species (Table 5). The immunopro-
tective rates in the groups, in which animals received a
rOmpL1 for immunization and challenge with the same
ompL1 gene type, appeared to be higher than those being
challenged with different ompL1 gene types.
In a previous study [35], we found L. interrogans serovar
Lai strain Lai could adhere to macrophages, and we here
show that adherence to macrophages could be blocked
with antisera against any of the rOmpL1 proteins, con-
firming cross-immunogenicity of OmpL1 proteins from
the three different groups. All these data collectively sug-
gest that OmpL1 is likely a genus-specific antigen.
Maximum parsimony trees for ompL1 nucleotide sequences  (A) and its amino acid sequences (B) of 15 standard strains Figure 1
Maximum parsimony trees for ompL1 nucleotide 
sequences (A) and its amino acid sequences (B) of 15 
standard strains. This figure shows the upper quartile, for 
the full image please see Additional file 1. The numbers at 
each fork node indicate the bootstrapping values (shown 
only when > 50%). RefSeq accession number and abbrevia-
tion for the organism are shown at each relevant branch. The 
scale bar indicates the number of character substitutions.
Comparison of the predicted secondary structures and anti- genic index of OmpL1 proteins Figure 2
Comparison of the predicted secondary structures 
and antigenic index of OmpL1 proteins. This figure 
shows the upper quartile, for the full image please see Addi-
tional file 2. The related strains of the same gene type just 
show the same predicted structure topology. Thus, only the 
results from three representative strains are showed here.BMC Microbiology 2008, 8:223 http://www.biomedcentral.com/1471-2180/8/223
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Conclusion
OmpL1 is a transmembrane protein extensively expressed
in pathogenic leptospires. Although the ompL1 gene can
belong to any of three different gene types, the OmpL1
proteins expressed by different gene types have conserved
immunogenicity and the specific antibodies generally
exist in sera of leptospirosis patients. OmpL1 should thus
be viewed as a potential candidate of genus-specific anti-
gen for the development of new universal vaccines and
serodiagnostic methods for leptospirosis.
Methods
Leptospiral strains and serum specimens
The National Institute for the Control of Pharmaceutical
and Biological Products (NICPBP) in Beijing, China, pro-
vided all 15 official Chinese standard strains belonging to
fifteen different pathogenic serogroups of Leptospira. In
addition, 163 clinical pathogenic Leptospiral isolates and
385 serum specimens from leptospirosis patients with
MAT titers of ≥ 1:100 were provided by the Centers of Dis-
ease Prevention and Control of Sichuan, Anhui and Zhe-
jiang provinces in China during 2004–2007 (Table 1). All
the leptospiral strains were cultured in liquid Korthof
medium containing 8% rabbit serum at 28°C [2,25]. All
the patients were clinically diagnosed suffering from acute
leptospirosis based on their medical history and clinical
symptoms, including fevers, jaundice, hemorrhaging,
myalgia and lymphadenectasis, as well as laboratory
examination. Finally, 36 sera samples with negative
results by MAT from healthy individuals for routine soma-
Expression and purification of recombinant OmpL1 proteins Figure 3
Expression and purification of recombinant OmpL1 proteins. Lanes 1 and 6: protein markers (BioColor); lane 2: 
pET42a with no inserted ompL1 genes; lanes 3 to 5: the expressed rOmpL1/1, rOmpL1/2 and rOmpL1/3, respectively; lanes 7 
to 9: the purified rOmpL1/1, rOmpL1/2 and rOmpL1/3, respectively.
Recognition of purified rOmpL1 proteins by sera from leptospirosis patients Figure 4
Recognition of purified rOmpL1 proteins by sera from leptospirosis patients. Lane 1: protein markers (BioColor); 
lanes 2–13: the rOmpL1/1, rOmpL1/2 and rOmpL1/3 hybridizing with the antisera from leptospirosis patients; lane 13: normal 
human serum used as control.BMC Microbiology 2008, 8:223 http://www.biomedcentral.com/1471-2180/8/223
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toscopy were offered by the First Affiliated Hospital of
Zhejiang University. Informed written consent for sample
collection was obtained from all participants and individ-
uals with ethical approval from the Ethics Committee of
Zhejiang University. This research was conducted in
accordance with the Declaration of Helsinki and with the
Guide for Care and Use of Laboratory Animals as adopted
and promulgated by the United States National Institutes
of Health. All experimental protocols were approved by
the Ethics Committee of Zhejiang University.
Cell line and cell culture
The murine monocyte/macrophage-like cell line, J774A.1,
was provided by the Cell Bank of the Institute of Cell Biol-
ogy in Shanghai, Chinese Academy of Science, and was
maintained in RPMI 1640 medium (GiBco, Grand Island,
The localization of OmpL1 on the surface of leptospires Figure 5
The localization of OmpL1 on the surface of leptospires. A: negative control; B to D: the immunogold particles binding 
to OmpL1/1, OmpL1/2 and OmpL1/3 on the surface of L. interrogans serovar Autumnalis strain Lin 4, serovar Lai strain Lai, and 
L. borgpetersenii serovars Ballum strain Pishu, respectively.BMC Microbiology 2008, 8:223 http://www.biomedcentral.com/1471-2180/8/223
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USA) supplemented with 10% fetal bovine serum (FBS)
(GiBco), and 100 U/ml penicillin and 100 μg/ml strepto-
mycin. The cells were cultured in 5% CO2 at 37°C.
Amplification and sequencing of ompL1 genes
Leptospiral DNA was extracted using Bacterial Genomic
DNA Extraction Kit (BioColor BioScience & Technology
Co., Shanghai, China) and then dissolved in TE buffer.
Density and purity of the extracted DNAs were detected by
UV spectrophotometery. One pair of primers was applied
to amplify the entire ompL1 gene. The upstream primer
was 5'-CCG CATATG (Nde I) ATC CGT AAC ATA AGT
AAG-3' and the downstream primer was 5'-CCG CTCGAG
(Xho I) GAG TTC GTG TTT ATA ACC-3'. A High Fidelity
PCR Kit (TaKaRa, Dalian, China), in which Taq-Pfu mix-
ture is used as DNA polymerase, was used to amplify the
target gene. The total volume per PCR was 50 μl which
included 20 pmol of each of the primers, 2.5 U Taq-Pfu
DNA polymerase, and 100 ng DNA templates. The reac-
tion mixture was initiated by incubation at 94°C for 5
min, followed by 30 cycles of amplification at 94°C for 30
s, 55°C for 30 s and 72°C for 90 s, and then incubation at
72°C for 10 min. The products were detected in 1.5%
ethidium bromide pre-stained agarose gel by agarose elec-
trophoresis. The target products were predicted to be 960
base pairs (bp) in size. To obtain more accurate sequence
data, the PCR products were purified using PCR Products
Purification Kit (BioColor) and then ligated into plasmid
pMD 18-T using T-A Cloning Kit (TaKaRa) [26]. The
cloned ompL1 genes of 15 standard strains and 39 clinical
strains were sequenced by Invitrogen (Shanghai, China).
Phylogenetic analysis and secondary structure prediction 
of OmpL1 protein
The similarity and homology of sequences were first eval-
uated with the BLASTN program of NCBI. Alignments
were carried out using ClustalX 1.83 software [27] and
manually adjusted using GeneDoc 2.7 software. The
amino acid sequences were deduced from their nucleotide
sequences. Phylogenetic analysis was carried out with
Maximum Parsimony (MP) and Maximum Likelihood
(ML) optimality criteria of the PAUP* package (Version
4.0b10) [28] and MEGA 3.1 software [29]. And the prob-
ability prediction for secondary structures [30,31], includ-
ing antigenic analysis [32] of OmpL1 proteins, was
computed using the protean program in DNAStar™ soft-
ware package.
Prokaryotic expression and preparation of antisera 
against OmpL1 proteins
The recombinant plasmids pMD18-T-ompL1/1/2/3 as well
as vector pET42a (Novagen, USA) were respectively
Table 3: MAT titers among anti-rOmpL1 antisera and 178 leptospiral strains
Strain Serovar Gene type MAT titer (1:xxx)
Anti-OmpL1/1 Anti-OmpL1/2 Anti-OmpL1/3
Standards (n = 15)
Lai Lai 2 400 400 200
M 10 Javanica 3 100 100 400
Lin Canicola 2 200 400 100
Pishu Ballum 3 100 200 400
Tian Pyrogenes 3 100 100 400
Lin 4 Autumnalis 1 400 400 200
65-9 Australis 2 200 400 100
Luo Pomona 2 200 400 100
Lin 6 Grippotyphosa 1 400 400 200
P 7 Hebdomadis 2 200 400 100
L 37 Paidjan 2 200 400 100
55-52 Tarassovi 3 100 200 400
L 105 Manhao II 2 200 400 100
L 183 Wolffi 1 400 200 100
Nan 10 Mini 3 100 100 200
Isolates (n = 163)
85 Lai 200~400 200~800 100~200
5 Canicola 200 400 100
4 Autumnalis 400 200~400 100
5 Australis 200 400 100
18 Pomona 200~400 200~800 100~200
11 Grippotyphosa 400~800 200~400 100~200
15 Hebdomadis 200~400 200~800 100~200
20 Medanesis 400 200~400 100~200BMC Microbiology 2008, 8:223 http://www.biomedcentral.com/1471-2180/8/223
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digested with Nde I and Xho I (TaKaRa). The recovered
ompL1 segments were respectively linked with the linear-
ized pET42a by T4 DNA ligase (TaKaRa) and then trans-
formed into E. coli BL21DE3 (Novagen). The three
constructed prokaryotic expression systems were induced
with 0.5 mM IPTG in LB medium to express recombinant
OmpL1 (rOmpL1). Expression of rOmpL1 was examined
by SDS-PAGE plus Gel Image Analyzor (BioRad, USA).
The expressed rOmpL1 proteins were extracted and puri-
fied by Ni-NTA affinity chromatography. New Zealand
white Rabbits provided by the Laboratory Animal Center,
Zhejiang University, were immunized intradermally with
each of the purified rOmpL1 proteins pre-mixed with Fre-
und's adjuvant for four times at an interval of once a week.
On the 15th day after the last immunization, the rabbit
sera were collected and the Immunodiffusion test was
used to examine the titers of antisera [24].
Western blot assay
Western blot analysis was used to identify the immunore-
activity of rOmpL1 proteins using 12 serum samples from
the patients diluted at 1:1000 (the same dilution of nor-
mal human sera was used as control) as the primary anti-
bodies, and 1:3000 diluted HRP-labeled goat anti-human
IgG (Jackson ImmunoResearch Laboratories Inc., USA) as
the secondary antibody.
Immuno-electron microscopy
Freshly-cultured L. interrogans serovar Autumnalis strain
Lin 4 (ompL1/1 gene type), serovar Lai strain Lai (ompL1/2
gene type), and L. borgpetersenii serovar Ballum strain
Pishu (ompL1/3 gene type) were centrifuged at 12, 000
rpm for 15 min at 15°C. The precipitates were fixed with
fresh 2% paraformaldehyde at 4°C for 24 h. Prepared sec-
tions were exposed to 5% FBS at room temperature for 30
Table 4: ELISA detection of rOmpL1-IgG/IgM in sera of leptospirosis patients
Sera Cases (n) Dilution (1:xxx) IgG-ELISA positive (n) IgM-ELISA positive (n)
rOmpL1/1 rOmpL1/2 rOmpL1/3 rOMPL1/1 rOMPL1/2 rOMPL1/3
Patients infected with:
Icterohaemorrhagia 191 50 / / / 145 161 139
100 159 187 149 132 152 128
200 147 162 135 / / /
Canicola 11 50 / / / 9 11 9
1 0 0 1 0 1 1 9896
2 0 0 8 1 0 6///
Autumnalis 13 50 / / / 13 11 9
1 0 0 1 31 21 01 0 8 7
2 0 01 2 9 7///
Pomona 44 50 / / / 38 41 31
1 0 0 3 84 33 33 13 52 6
2 0 0 3 33 72 7 / / /
Australis 13 50 / / / 12 13 10
1 0 0 1 21 31 01 01 1 7
2 0 01 0 1 1 8///
Grippotyphosa 31 50 / / / 29 26 22
1 0 0 3 02 62 32 32 11 6
2 0 0 2 62 31 6 / / /
Hebdomadis 37 50 / / / 34 35 30
1 0 0 3 33 63 02 93 02 5
2 0 0 2 83 12 4 / / /
Sejroe 45 50 / / / 41 37 36
1 0 0 4 33 83 53 73 22 8
2 0 0 3 73 32 9 / / /
Total 385 50 / / / 321 335 286
100 338 366 299 280 298 243
200 301 316 252 / / /
Healthy individuals: 36 50 / / / 0.20 ± 0.06 0.20 ± 0.07 0.19 ± 0.07
Cut-off / / / 0.38 0.41 0.40
100 0.17 ± 0.05 0.18 ± 0.05 0.17 ± 0.06 0.18 ± 0.05 0.17 ± 0.06 0.17 ± 0.05
Cut-off 0.32 0.33 0.35 0.33 0.35 0.32
200 0.14 ± 0.04 0.13 ± 0.05 0.15 ± 0.04 / / /
Cut-off 0.26 0.28 0.27 / / /
Note: the mean at OD490 + 3 SD = cut-off valueBMC Microbiology 2008, 8:223 http://www.biomedcentral.com/1471-2180/8/223
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min to block unspecific antigens, and then incubated with
each 1:1000 diluted rOmpL1s rabbit antisera or preim-
mune normal rabbit sera (negative control) as the first
antibody and 1:2000 diluted colloidal gold (12 nm)-
labeled goat anti-rabbit IgG (Jackson ImmunoResearch
Laboratories) as the second antibody. The locations of
OmpL1s were determined under transmission electron
microscope (Philips TECNAL-10, Eindhoven, Hol-
land)[16].
Microscopic agglutination test
The microscopic agglutination test (MAT) was used to
determine cross-immunoagglutination under dark-field
microscopy using rabbit antisera against the rOmpL1 pro-
teins reacting with the 15 freshly-cultured standard strains
Inhibition of leptospiral adherence to J744A.1 macrophages in the presence anti-rOmpL1 antiserum Figure 6
Inhibition of leptospiral adherence to J744A.1 macrophages in the presence anti-rOmpL1 antiserum. A: Lepto-
spires binding to macrophages in the presence of irrelevant antisera. B: inhibition of leptospiral binding to macrophages in the 
presence of antiserum against recombinant OmpL1 protein (amplification ×1000).
Table 5: Immunoprotective effects of rOmpL1 proteins in guinea pigs
Group Animals (n) Immunizing dosage (mg/kg) Infecting Leptospiral Survival/Death Protective rate
rOmpL1/1 rOmpL1/2 rOmpL/3 strain (n/n) (%)
A1 8 1.0 / / Lai 3/5 37.5
A2 8 2.0 / / Lai 5/3 62.5
A3 8 1.0 / / Lin 4 5/3 62.5
A4 8 2.0 / / Lin 4 7/1 87.5
A5 8 1.0 / / Pishu 2/6 25.0
A6 8 2.0 / / Pishu 3/5 37.5
B1 8 / 1.0 / Lai 5/3 62.5
B2 8 / 2.0 / Lai 6/2 75.0
B3 8 / 1.0 / Lin 4 4/4 50.0
B4 8 / 2.0 / Lin 4 5/3 62.5
B5 8 / 1.0 / Pishu 2/6 25.0
B6 8 / 2.0 / Pishu 3/5 37.5
C1 8 / / 1.0 Lai 2/6 25.0
C2 8 / / 2.0 Lai 3/5 37.5
C3 8 / / 1.0 Lin 4 3/5 37.5
C4 8 / / 2.0 Lin 4 4/4 50.0
C5 8 / / 1.0 Pishu 5/3 62.5
C6 8 / / 2.0 Pishu 6/2 75.0
D1 8 / / / Lai 0/8 /
D2 8 / / / Lin 4 0/8 /
D3 8 / / / Pishu 0/8 /BMC Microbiology 2008, 8:223 http://www.biomedcentral.com/1471-2180/8/223
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and 163 clinical isolates of leptospires, in which normal
saline was used as negative control [2,33].
ELISA assay with rOmpL1 proteins
Enzyme-linked immunosorbent assays (ELISAs) were
used to detect rOmpL1/1 or rOmpL1/2-specific IgM or
IgG. Briefly, 96-well plates were coated with 50 μg/ml
rOmpL1/1 or rOmpL1/2 (100 μl per well) at 4°C over-
night, and then incubated with 5% FBS for 30 min to
block unspecific binding. Using the diluted serum speci-
mens from patients or normal individuals (1:50 or 1:100
dilution for IgM detection, and 1:100 or 1:200 dilution
for IgG detection) as the primary antibody, HRP-labeling
goat anti-human IgM (1:3000 dilution) or IgG (1:4000
dilution) (Jackson ImmunoResearch Laboratories) as the
secondary antibody, and o-phenvlenediamine (OPD) as
the substrate, the rOmpL1 proteins-specific IgM or IgG
were examined under a Microplate Reader (Model 550,
BioRad). OD490 values over the mean plus 3 SD of the 36
normal serum specimens were defined as positive [34].
Adherence inhibition test
J774A.1 cells (1 × 105 cells in 1 ml medium per well) were
inoculated in 12-well plates (Corning, USA) containing
glass cover slips, incubated at 37°C for 24 h. Freshly-
grown cultures of L. interrogans serovar Lai strain Lai were
centrifuged at 10,000 rpm for 15 min at 15°C, and the
precipitates were then suspended in antibiotics-free RPMI
1640 medium (GiBco) to a final concentration of 108/ml.
The antisera against rOmpL1 proteins were serially dou-
ble-diluted with antibiotics-free RPMI 1640 medium (1:2
to 1:32), then mixed with the same volumes of each lept-
ospiral suspension. The mixtures were incubated at 37°C
for 1 h. The medium in the 12-well plates was removed,
and then the plates were repeatedly washed with antibi-
otic-free RPMI1640 medium. The mixtures were added
into the plates to incubate at 37°C for 1 h. After the incu-
bation, the plates were repeatedly washed with PBS to
remove non-adhered leptospires, and the Fontana silver-
stained leptospires adhering J774A.1 cells were observed
under light microscope [35]. In this test, preimmune rab-
bit serum instead of the antisera was used as control.
Immunoprotective test in guinea pigs
Dunkin-Hartley guinea pigs (150 ± 5 g, 3 weeks old) used
in this study were provided by Laboratory Animal Center
of Zhejiang University (certificate no. SCXK [zhe]2007-
0030). L. interrogans serovar Lai strain Lai, serovar Autum-
nalis strain Lin 4, and L. borgpetersenii serovar Bullum
stain Pishu were maintained by serial passage in guinea
pigs for preservation of virulence before use for challenge.
Eighteen groups of guinea pigs (A1–6, B1–6, and C1–C6)
were subcutaneously immunized twice at an interval of
once a week with different dosages of rOmpL1/1,
rOmpL1/2 and rOmpL1/3, respectively. In addition,
another three groups of guinea pigs (D1-3) were immu-
nized with bovine serum albumin (BSA) (Sigma, USA) as
control. Each protein antigen was pre-mixed with 0.7 mg
aluminum hydroxide (Sigma) [36]. On the 15th day after
the last immunization, the animals were challenged intra-
peritoneally with lethal doses of strain Lai, strain Lin 4 or
strain Pishu and then observed for another 7 days.
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